1–1 of 1 result for David S Liao
Extended Efficacy and Safety of MCO-010 Optogenetic Therapy for RP: 126-Week Results From the RESTORE Follow-Up Study (REMAIN)
David S Liao, MD, PhD
Annual Meeting Talks
2025